Skip to Main Content

Paper Details

Therapeutic targeting of preleukemia cells in a mouse model of <i>NPM1</i> mutant acute myeloid leukemia.
Science
141
2020
AML, Acute myeloid leukemia, Dnmt3a, MLL1, Menin, NPM1 mutant, NPM1 mutant acute myeloid leukemia, Npm1c, VTP-50469, cancer, leukemia, mice, mouse, myelodysplastic syndrome, myeloid progenitor cell, preleukemia cells, premalignant, premalignant cells
Author NameAffiliation
Charlie HattonDana-Farber Cancer Institute
Charlie HattonBoston Children's Hospital and Harvard Medical School
Gerard M McGeehanSyndax Pharmaceuticals, Inc.
Scott A ArmstrongDana-Farber Cancer Institute
Scott A ArmstrongBoston Children's Hospital and Harvard Medical School
Scott A ArmstrongDana-Farber Cancer Institute
Scott A ArmstrongBoston Children's Hospital and Harvard Medical School
  • 1 - 7

Datasets

Release 1.2